Health Care·Health Care Equipment·$17.7B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.11 | N/A | +2.38% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $2.11 | N/A | +2.38% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed confidence in their strategic direction despite the ongoing challenges in the market. They emphasized their focus on innovation and efficiency.
We are navigating through a challenging environment while focusing on our strategic priorities.
Our commitment to innovation and operational efficiency remains strong.
Zimmer Biomet's earnings report shows a positive surprise on EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 0.5%. This could suggest investor concerns about future revenue growth or broader market conditions despite the EPS beat.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AMGEN INC
Feb 2, 2021